Katherine Andersen is a senior market manager covering Healthcare Corporate Finance in the U.S. in addition to the East and Central regions for SVB’s national Life Science practice. She also sits on the Board of Directors for SVB's China Joint Venture. Prior to SVB, Katherine was a Senior Vice President for Wells Fargo Bank leading the Life Sciences business development and relationship management efforts for the New England region. Before that, she was a Director at Wells Fargo Capital Finance focused on front-end business development and underwriting of structured loans, ultimately totaling over $3.0B in commitments. Prior to Wells, she held various positions across mergers and acquisitions, finance, equity derivatives, audit, and management while at Affiliated Managers Group, Merrill Lynch, GE Corporate Audit Staff and GE Capital. Katherine has a bachelor’s degree in finance and economics from Virginia Tech. She has also completed Dartmouth’s Tuck Executive Leadership and Strategic Impact Program, Wells Fargo’s Transformational Leadership Program, the Program on Negotiation at Harvard Law School and the GE Capital Financial Management Program. Away from work, Katherine serves on the Finance Advisory Board for Virginia Tech, the Advisory Board for the WEST Organization, and Chairs the Corporate Council for the American Cancer Society’s AstraZeneca Hope Lodge.

Cynthia Bai focuses her practice on secured debt facilities, with an emphasis on venture debt finance and capital call facilities. Her clients include banks, venture lending funds and companies. Prior to joining Cooley, Cynthia was an associate at Wilson Sonsini Goodrich & Rosati in Palo Alto, California. During her attendance at Cornell Law School, she served as managing editor for the International Law Journal. She grew up in Germany, has lived in France and Korea prior to moving to the US. Cynthia is fluent in German, French and Korean. Her degrees include: JD from Cornell Law School and BS in Economics from the Univ. Washington. Cynthia is a member of the State Bar of California.

As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Bob has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick's administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Bob has also held senior executive positions in the environmental services, capital management and venture capital industries. He brings passion and energy to all of his endeavors.

Matt is a Partner and the chair of Morse’s Employment Law Group. He is experienced in the broad range of complex laws that affect the relationships between employers and employees, including wage and hour, noncompetition, employee leave, employee classification, independent contractor, and anti-discrimination laws. He holds a JD from Cornell School of Law and BA, Phi Beta Kappa; magna cum laude from Brandeis University.